Outsourcing to exploit a key asset.

Area of Science:

• Pharmaceutical Sciences
• Drug Discovery
• Chemical Management

Background:

• The pharmaceutical industry increasingly utilizes outsourcing for various drug discovery operations.
• A modular approach to drug discovery involves specialist suppliers handling specific process sections.
• Managing internal and external chemical intermediates presents a significant organizational challenge.

Purpose of the Study:

• To report on a novel outsourced solution for consolidating and managing chemical intermediates.
• To establish a single-source solution for scientists requiring chemical intermediates at Johnson and Johnson Pharmaceutical Research and Development.

Main Methods:

• Development of an outsourced solution in partnership with Sigma-Aldrich.
• Consolidation and management of a large, long-standing chemical intermediate resource.
• Integration of internally generated and externally procured intermediates.

Main Results:

• Successful implementation of a centralized chemical intermediate management system.
• Improved accessibility and management of critical research assets.
• Facilitation of drug discovery processes through a unified resource.

Conclusions:

• Outsourced solutions can effectively address complex asset management challenges in large research organizations.
• Partnerships with specialist suppliers can provide innovative solutions for drug discovery operations.
• A centralized chemical intermediate resource streamlines research and development efforts.